Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ezetimibe Tablets in Healthy Subjects
NCT04814589Phase 1Unknown
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms). Primary endpoints: Peak Plasma Concentration at 90 days, Area under the plasma concentration versus time curve from time 0 to time t at 90 days and 1 more. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04814589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04814589.